Monday, June 16, 2014
novel brain tumor vaccine trial
For those of you eager for news on the cancer-fighting agent front, Elizabeth Hayes Staff Reporter, Portland Business Journal writes that “Brain and cancer experts at Providence Health & Services have begun a research trial that will use immunotherapy to target adult brain tumors.”
According to her article, “Providence researcher Keith Bahjat came up with the idea, after working with Listeria monocytogenes, a bacterium that can cause serious illness in people with compromised immune systems. He collaborated with scientists at Aduro BioTech who engineered a version of the Listeria bacterium for use as a cancer vaccine.”
Importantly, “The bacteria is not going to go near the tumor, but be recognized by the immune system and the same immune response is going to hit the cancer cells,” Bahjat said.
Interested? Here’s a link: http://www.bizjournals.com/portland/blog/health-care-inc/2014/05/providence-begins-novel-brain-tumor-vaccine-trail.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_portland+%28Portland+Business+Journal%29